MAP2K7 and melanoma: The giant IAP Apollon was recently shown by us to have a relevant role in suppressing melanoma response to MEK inhibitors and to TRAIL.27 Silencing experiments, by previously validated siRNA,27 confirmed the central role of Apollon downmodulation in promoting the apoptotic response of melanoma cells even to these combinatorial treatments.